Risk Stratification of Post Tonsillectomy Respiratory Complications in the Pediatric Population
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Obstructive sleep apnea syndrome (OSAS) is the most common indication for tonsillectomy and adenoidectomy in young children. According to previous studies, as much as 8 to 20% of patients will develop post operative respiratory complications requiring medical intervention. The pre-operative risk factors that could predict respiratory complications retrospectively analyzed were young age, obesity and high preoperative apnea-hypopnea index. Despite the removal of obstructing lymphoid tissue, upper airway obstruction occurs on the first postoperative night in children with OSA. There is a debate regarding the post-operative duration and monitoring needed in children with OSA.
Hypothesis:
Pre-operative, operative and immediate post-operative parameters could predict post tonsillectomy respiratory complications.
| Condition |
|---|
|
Post Tonsillectomy Respiratory Complications |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Crossover Time Perspective: Prospective |
- respiratory distress
| Estimated Enrollment: | 200 |
| Groups/Cohorts |
|---|
|
post tonsillectomy
children
|
Eligibility| Ages Eligible for Study: | up to 14 Years |
| Genders Eligible for Study: | Both |
| Sampling Method: | Probability Sample |
children, suffering of obstructive sleep apnea, having their tonsills removed
Inclusion Criteria:
- Pediatric patient < 14 years old
- Obstructive sleep apnea according to polysomnography
- Surgery: Tonsillectomy/Tonsillotomy
Exclusion Criteria:
1. Patient suffering from known respiratory disease
Contacts and Locations| Contact: Nir Hirshoren, MD | 0097226776476 | drnir@hadassah.org.il |
| Contact: Hadas Lemberg, PhD | 00972267777572 | lhadas@hadassah.org.il |
| Israel | |
| Hadassah Medical Organization | Not yet recruiting |
| Jerusalem, Israel | |
| Contact: Arik Tzukert, DMD 0097226776095 arik@hadassah.org.il | |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT01257321 History of Changes |
| Other Study ID Numbers: | OSA-HMO-CTIL |
| Study First Received: | December 8, 2010 |
| Last Updated: | December 8, 2010 |
| Health Authority: | Israel: Ministry of Health - Director General |
ClinicalTrials.gov processed this record on June 17, 2013